FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386291749> ?p ?o ?g. }

• W4386291749 abstract "Introduction Insomnia affects daily functioning and overall health, and is thus associated with significant individual, societal, and economic burden. The experience of patients living with insomnia, their perception of the condition, and its impact on their quality of life is not well documented. The objective of this study was to map the patient journey in insomnia and identify unmet needs. Methods Participants were individuals with insomnia, and healthcare professionals (HCPs) who treat insomnia, in the United Kingdom, France, Germany, Italy, and Canada. Qualitative interviews (50 patients, 70 HCPs) and a quantitative survey (700 patients, 723 HCPs) were conducted to inform the patient-journey mapping and obtain information on the emotions, perceptions, and experiences of patients and HCPs. Results The patient journey comprises seven phases. The first defines the onset of insomnia symptoms. Phase 2 represents self-initiated behavior change to improve sleep (e.g., sleep hygiene, reducing caffeine, exercise). The next phase is characterized by use of over-the-counter (OTC) treatments, which generally fail to provide lasting relief. Phase 4 describes the first HCP consultation (occurring several months to several years after onset) and typically occurs at a crisis point for the patient; patients may be looking for an immediate solution (e.g., medication), which may not align with their HCP’s recommendation. The following stage comprises sleep hygiene/behavioral changes (±OTC treatment) under HCP guidance for many patients, although offering prescription treatments without a sleep hygiene stage under supervision is more common in some countries. Phase 6 describes prescription medication initiation, where patients fluctuate between relief/hopefulness and a sense of failure, while HCPs try to balance the need to provide relief for the patient while maintaining best medical practice and minimizing adverse effects. The final phase (living with long-term insomnia) represents an indefinite period during which sleep issues remain unresolved for many patients, with most of them continuing to use prescription treatments for longer than indicated and creating their own variable, self-managed regimens combining multiple modalities. Conclusion This patient journey analysis for insomnia revealed seven distinct phases, highlighting different touchpoints where insomnia management could be optimized." @default.
• W4386291749 created "2023-08-31" @default.
• W4386291749 creator A5016670574 @default.
• W4386291749 creator A5039103210 @default.
• W4386291749 creator A5040158309 @default.
• W4386291749 creator A5047453884 @default.
• W4386291749 creator A5078047058 @default.
• W4386291749 creator A5092718448 @default.
• W4386291749 date "2023-08-29" @default.
• W4386291749 modified "2023-09-27" @default.
• W4386291749 title "Mapping the insomnia patient journey in Europe and Canada" @default.
• W4386291749 cites W182673633 @default.
• W4386291749 cites W1965622047 @default.
• W4386291749 cites W1978312037 @default.
• W4386291749 cites W1984151168 @default.
• W4386291749 cites W1987459742 @default.
• W4386291749 cites W1989342899 @default.
• W4386291749 cites W2012299546 @default.
• W4386291749 cites W2018449766 @default.
• W4386291749 cites W2030053080 @default.
• W4386291749 cites W2051447719 @default.
• W4386291749 cites W2075855743 @default.
• W4386291749 cites W2077227006 @default.
• W4386291749 cites W2080195746 @default.
• W4386291749 cites W2082850379 @default.
• W4386291749 cites W2084848253 @default.
• W4386291749 cites W2111203770 @default.
• W4386291749 cites W2132954199 @default.
• W4386291749 cites W2141148178 @default.
• W4386291749 cites W2147677399 @default.
• W4386291749 cites W2148483180 @default.
• W4386291749 cites W2163166459 @default.
• W4386291749 cites W2167926736 @default.
• W4386291749 cites W2253781173 @default.
• W4386291749 cites W2347166707 @default.
• W4386291749 cites W2416963814 @default.
• W4386291749 cites W2482247528 @default.
• W4386291749 cites W2527790276 @default.
• W4386291749 cites W2578164715 @default.
• W4386291749 cites W2747571222 @default.
• W4386291749 cites W2753866150 @default.
• W4386291749 cites W2767159911 @default.
• W4386291749 cites W2770886369 @default.
• W4386291749 cites W2793017265 @default.
• W4386291749 cites W2795657325 @default.
• W4386291749 cites W2803370373 @default.
• W4386291749 cites W2890050045 @default.
• W4386291749 cites W2921836189 @default.
• W4386291749 cites W2969086610 @default.
• W4386291749 cites W2970438846 @default.
• W4386291749 cites W2979550270 @default.
• W4386291749 cites W2986197516 @default.
• W4386291749 cites W2986477656 @default.
• W4386291749 cites W2991541757 @default.
• W4386291749 cites W3003816362 @default.
• W4386291749 cites W3008156213 @default.
• W4386291749 cites W3010734355 @default.
• W4386291749 cites W3011773752 @default.
• W4386291749 cites W3022940165 @default.
• W4386291749 cites W3026890652 @default.
• W4386291749 cites W3094332143 @default.
• W4386291749 cites W3117148433 @default.
• W4386291749 cites W3153602294 @default.
• W4386291749 cites W3169571379 @default.
• W4386291749 cites W3204460320 @default.
• W4386291749 cites W3206674638 @default.
• W4386291749 cites W3207218885 @default.
• W4386291749 cites W3208631643 @default.
• W4386291749 cites W4210604792 @default.
• W4386291749 cites W4248040209 @default.
• W4386291749 cites W4283695295 @default.
• W4386291749 cites W4307953895 @default.
• W4386291749 cites W4322619453 @default.
• W4386291749 cites W4383854511 @default.
• W4386291749 cites W86291341 @default.
• W4386291749 doi "https://doi.org/10.3389/fpubh.2023.1233201" @default.
• W4386291749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37711247" @default.
• W4386291749 hasPublicationYear "2023" @default.
• W4386291749 type Work @default.
• W4386291749 citedByCount "0" @default.
• W4386291749 crossrefType "journal-article" @default.
• W4386291749 hasAuthorship W4386291749A5016670574 @default.
• W4386291749 hasAuthorship W4386291749A5039103210 @default.
• W4386291749 hasAuthorship W4386291749A5040158309 @default.
• W4386291749 hasAuthorship W4386291749A5047453884 @default.
• W4386291749 hasAuthorship W4386291749A5078047058 @default.
• W4386291749 hasAuthorship W4386291749A5092718448 @default.
• W4386291749 hasBestOaLocation W43862917491 @default.
• W4386291749 hasConcept C118552586 @default.
• W4386291749 hasConcept C15744967 @default.
• W4386291749 hasConcept C159110408 @default.
• W4386291749 hasConcept C160735492 @default.
• W4386291749 hasConcept C162324750 @default.
• W4386291749 hasConcept C169760540 @default.
• W4386291749 hasConcept C2426938 @default.
• W4386291749 hasConcept C26760741 @default.
• W4386291749 hasConcept C2779951463 @default.
• W4386291749 hasConcept C2780975770 @default.
• W4386291749 hasConcept C2781210498 @default.
• W4386291749 hasConcept C2983189541 @default.

• next